Possible drugs for the treatment of bacterial infections in the future: anti-virulence drugs

被引:35
|
作者
Ogawara, Hiroshi [1 ,2 ]
机构
[1] HO Bio Inst, Tokyo, Japan
[2] Meiji Pharmaceut Univ, Dept Biochem, Tokyo, Japan
关键词
QUORUM-SENSING INHIBITORS; COMPLETE GENOME SEQUENCE; NATURAL GENETIC-TRANSFORMATION; TYPE-3 SECRETION SYSTEM; ANTIBIOTIC-RESISTANCE; IV SECRETION; PSEUDOMONAS-AERUGINOSA; III SECRETION; ESCHERICHIA-COLI; STAPHYLOCOCCUS-AUREUS;
D O I
10.1038/s41429-020-0344-z
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Antibiotic resistance is a global threat that should be urgently resolved. Finding a new antibiotic is one way, whereas the repression of the dissemination of virulent pathogenic bacteria is another. From this point of view, this paper summarizes first the mechanisms of conjugation and transformation, two important processes of horizontal gene transfer, and then discusses the approaches for disarming virulent pathogenic bacteria, that is, virulence factor inhibitors. In contrast to antibiotics, anti-virulence drugs do not impose a high selective pressure on a bacterial population, and repress the dissemination of antibiotic resistance and virulence genes. Disarmed virulence factors make virulent pathogens avirulent bacteria or pathobionts, so that we human will be able to coexist with these disarmed bacteria peacefully.
引用
收藏
页码:24 / 41
页数:18
相关论文
共 50 条
  • [1] Peptidomimetics as Potential Anti-Virulence Drugs Against Resistant Bacterial Pathogens
    Martinez, Osmel Fleitas
    Duque, Harry Morales
    Franco, Octavio Luiz
    FRONTIERS IN MICROBIOLOGY, 2022, 13
  • [2] Evaluation of novel compounds as anti-bacterial or anti-virulence agents
    Filipic, Brankica
    Usjak, Dusan
    Rambaher, Martina Hrast
    Oljacic, Slavica
    Milenkovic, Marina T.
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2024, 14
  • [3] Anti-virulence therapeutic strategies against bacterial infections: recent advances
    Dehbanipour, Razieh
    Ghalavand, Zohreh
    GERMS, 2022, 12 (02): : 262 - 275
  • [4] Repurposing of Anticancer Drugs for the Treatment of Bacterial Infections
    Soo, Valerie W. C.
    Kwan, Brian W.
    Quezada, Hector
    Castillo-Juarez, Israel
    Perez-Eretza, Berenice
    Julieta Garcia-Contreras, Silvia
    Martinez-Vazquez, Mariano
    Wood, Thomas K.
    Garcia-Contreras, Rodolfo
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2017, 17 (10) : 1157 - 1176
  • [5] Recent Developments in the Inhibition of Bacterial Adhesion as Promising Anti-Virulence Strategy
    Pecoraro, Camilla
    Carbone, Daniela
    Parrino, Barbara
    Cascioferro, Stella
    Diana, Patrizia
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (05)
  • [6] Development and characterization of improved β-lactone-based anti-virulence drugs targeting ClpP
    Zeiler, Evelyn
    Korotkov, Vadim S.
    Lorenz-Baath, Katrin
    Boettcher, Thomas
    Sieber, Stephan A.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (02) : 583 - 591
  • [7] Exploring the anti-virulence potential of plants used in traditional Mayan medicine to treat bacterial infections
    Munoz-Cazares, Naybi
    Pena-Gonzalez, Maria Claudia
    Castillo-Juarez, Israel
    Diaz-Nunez, Jose Luis
    Pena-Rodriguez, Luis Manuel
    JOURNAL OF ETHNOPHARMACOLOGY, 2023, 317
  • [8] Computational and Biological Evaluation of β-Adrenoreceptor Blockers as Promising Bacterial Anti-Virulence Agents
    Almalki, Ahmad J.
    Ibrahim, Tarek S.
    Elhady, Sameh S.
    Hegazy, Wael A. H.
    Darwish, Khaled M.
    PHARMACEUTICALS, 2022, 15 (02)
  • [9] Comprehensive Host Cell-Based Screening Assays for Identification of Anti-Virulence Drugs Targeting Pseudomonas aeruginosa and Salmonella Typhimurium
    von Ambueren, Julia
    Schreiber, Fynn
    Fischer, Julia
    Winter, Sandra
    van Gumpel, Edeltraud
    Simonis, Alexander
    Rybniker, Jan
    MICROORGANISMS, 2020, 8 (08) : 1 - 14
  • [10] Controlling of Bacterial Virulence: Evaluation of Anti-Virulence Activities of Prazosin against Salmonella enterica
    Elfaky, Mahmoud A.
    Thabit, Abrar K.
    Eljaaly, Khalid
    Zawawi, Ayat
    Abdelkhalek, Ahmed S.
    Almalki, Ahmad J.
    Ibrahim, Tarek S.
    Hegazy, Wael A. H.
    ANTIBIOTICS-BASEL, 2022, 11 (11):